Anúncio
Anúncio
MBRX
Moleculin Biotech, Inc.
3.95
USDPatrocinado
-0.16
-3.82%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
3.88
-0.07
-1.85%
Relatórios de Lucros MBRX
Rácio de surpresa positiva
MBRX separação 19 de 33 últimas estimativas.
58%
Próximo Relatório
Data do Próximo Relatório
19 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$7.92
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-53.41%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-15.02%
Moleculin Biotech, Inc. earnings per share and revenue
On 13 de nov. de 2025, MBRX reported earnings of -17.00 USD per share (EPS) for Q3 25, missing the estimate of -4.97 USD, resulting in a -241.88% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.43% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -7.92 USD, with revenue projected to reach -- USD, implying an diminuir of -53.41% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Moleculin Biotech, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Moleculin Biotech, Inc. reported EPS of -$17.00, missing estimates by -241.88%, and revenue of $0.00, 0% as expectations.
How did the market react to Moleculin Biotech, Inc.'s Q3 2025 earnings?
The stock price moved down -4.43%, changed from $11.35 before the earnings release to $10.85 the day after.
When is Moleculin Biotech, Inc. expected to report next?
The next earning report is scheduled for 19 de mar. de 2026.
What are the forecasts for Moleculin Biotech, Inc.'s next earnings report?
Based on 4
analistas, Moleculin Biotech, Inc. is expected to report EPS of -$7.92 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio